钙剂量相关增强L-色氨酸对肥胖者肠道激素与能量摄入的作用
在15名无2型糖尿病的肥胖男性中,随机双盲交叉设计比较十二指肠内灌注0、500或1000 mg钙联合L-色氨酸(0.1 kcal/min,t=75-150分钟)对肠道激素、幽门压力和能量摄入的影响;1000 mg钙增强色氨酸刺激CCK、GLP-1和PYY并更大程度抑制能量摄入(P=.01)。
要点
- 1000 mg钙联合色氨酸增强CCK、GLP-1和PYY分泌(均P<.05)并更大程度抑制能量摄入(P=.01)。
- 能量摄入与钙剂量呈负相关(R=-0.64;P=.001),CCK、GLP-1、PYY与钙剂量呈正相关。
- 1000 mg钙单用即可刺激GLP-1、PYY和幽门压力(均P<.05)。
核心结论
- 十二指肠内钙增强十二指肠内色氨酸刺激CCK、GLP-1和PYY并抑制肥胖男性能量摄入的作用。
研究设计与样本
- 随机、双盲、交叉研究,纳入15名无2型糖尿病的肥胖男性(平均±SD:年龄27±8岁;BMI 30±2 kg/m2;HbA1c 5.3±0.2%)。
- 受试者分别接受150分钟十二指肠内灌注0、500或1000 mg钙,每种剂量联合色氨酸(负荷0.1 kcal/min,已知具有次最大能量摄入抑制效应),色氨酸于t=75-150分钟给予,共3次独立 occasion。
主要发现
- 1000 mg钙单用刺激GLP-1、PYY和幽门压力(均P<.05)。
- 1000 mg钙增强色氨酸刺激CCK、GLP-1和PYY(均P<.05),并伴随更明显的能量摄入抑制(P=.01)。
- 能量摄入与钙剂量呈负相关(R=-0.64;P=.001)。
- 血浆CCK(R=0.44;P=.05)、GLP-1(R=0.60;P=.01)、PYY(R=0.83;P=.01)浓度与钙剂量呈正相关。
关键数值与推荐
- 色氨酸负荷为0.1 kcal/min,于t=75-150分钟灌注,已知具有次最大能量摄入抑制效应。
- 钙剂量为0、500或1000 mg,溶于150分钟十二指肠内灌注。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: In males of normal weight, intraduodenal administration of calcium enhances the effects of the amino acid L-tryptophan (Trp) to suppress energy intake, associated with greater stimulation of cholecystokinin (CCK), glucagon-like peptide-1 (GLP-1), and peptide tyrosine-tyrosine (PYY) secretion (key mechanisms underlying the regulation of pyloric motility and gastric emptying) but not gastrin or glucose-dependent insulinotropic polypeptide (GIP). OBJECTIVE: Given the implications for the management of obesity, the current study evaluated the effects of calcium, when administered alone and in combination with Trp, on gut hormone secretion, antropyloroduodenal motility, and energy intake in males with obesity. METHODS: Fifteen males with obesity and without type 2 diabetes (mean ± SD; age: 27 ± 8 years; body mass index: 30 ± 2 kg/m2; hemoglobin A1c: 5.3 ± 0.2%), received 150-minute intraduodenal infusions of 0, 500, or 1000 mg calcium, each combined with Trp (load: 0.1 kcal/min, known to have submaximal energy-intake suppressant effects) from t = 75-150 minutes, on 3 separate occasions, in a randomized, double-blind, cross-over order. Plasma concentrations of gastrin, CCK, GIP, GLP-1, PYY, and pyloric pressures were measured during the infusions. Immediately postinfusion (t = 150-180 minutes), energy intake at a standardized buffet-style lunch was quantified. RESULTS: Calcium, in a dose of 1000 mg, stimulated GLP-1, PYY, and pyloric pressures alone (all P < .05) and enhanced the effects of Trp to stimulate CCK, GLP-1, and PYY (all P < .05), associated with greater suppression of energy intake (P = .01). Energy intake (R = -0.64; P = .001) was inversely related to the dose of calcium, while plasma concentrations of CCK (R = 0.44; P = .05), GLP-1 (R = 0.60; P = .01), and PYY (R = 0.83; P = .01) were directly related. CONCLUSION: Intraduodenal calcium enhances the effect of intraduodenal Trp to stimulate CCK, GLP-1, and PYY and suppress energy intake in males with obesity.
引用
- Anjom-Shoae J, Fitzgerald PCE, Horowitz M, et al. Dose-related Effects of Calcium to Enhance the Effects of L-tryptophan on Gut Hormones and Energy Intake in Obesity. J Clin Endocrinol Metab. 2025. PMID: 39785828. doi:10.1210/clinem/dgaf008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。